Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-024820
Filing Date
2025-08-19
Accepted
2025-08-19 16:01:23
Documents
1
Period of Report
2025-08-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5425
  Complete submission text file 0001641172-25-024820.txt   6897
Mailing Address C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370 EMERYVILLE CA 94608
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-41583 | Film No.: 251231657

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)